This is the goal of Positron Emission Tomography (PET)-based molecular imaging-turning the concept of early health into reality. A vision GE Healthcare is helping to make possible with today’s most advanced and comprehensive PET imaging solutions.

From cutting-edge scanners for pre-clinical research to high-performance PET/CT imaging systems for enhanced clinical applications, this portfolio of offerings addresses the needs of a successful molecular imaging program. Central to this program is PET Radiopharmacy.

PET Radiopharmacy offers the components that are key to establishing a molecular imaging program: a cyclotron for isotope production, a PET chemistry synthesis platform for production and development of new tracers, and the expertise, support and partnership only GE Healthcare can offer to help bring your PET imaging to life. Within these pages, you’ll discover how GE Healthcare is uniquely suited to provide you with products, technology and expertise you need to lead the way into the future of early health.